Compare SLDB & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLDB | KELYB |
|---|---|---|
| Founded | 2013 | 1946 |
| Country | United States | United States |
| Employees | N/A | 5570 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.6M | 513.9M |
| IPO Year | 2017 | N/A |
| Metric | SLDB | KELYB |
|---|---|---|
| Price | $8.39 | $15.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $16.36 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 16.4K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.86% |
| EPS Growth | ★ 34.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,094,000.00 | N/A |
| Revenue This Year | N/A | $0.72 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.51 | $8.38 |
| 52 Week High | $8.87 | $125.00 |
| Indicator | SLDB | KELYB |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 57.42 |
| Support Level | $5.16 | $11.66 |
| Resistance Level | N/A | $18.58 |
| Average True Range (ATR) | 0.59 | 0.96 |
| MACD | 0.07 | 0.25 |
| Stochastic Oscillator | 81.71 | 52.75 |
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services to a diverse group of clients operating in the Americas, Europe, and the Asia-Pacific region across various industries. The company's reportable segments are: Enterprise Talent Management, Science, Engineering and Technology, and Education. Maximum revenue is generated from its Enterprise Talent Management segment, which delivers temporary staffing, outcome-based, and permanent placement services focused on light industrial, contact center, and office and clerical specialties in North America across various industries. It also provides talent supply chain and workforce talent solutions, including MSP, RPO, and PPO solutions to its clients. Geographically, it derives key revenue from the USA.